Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $201 | $81 | $59 | $111 |
| Short-Term Investments | $0 | $0 | $0 | $2 |
| Receivables | $924 | $849 | $800 | $776 |
| Inventory | $615 | $609 | $601 | $612 |
| Other Curr. Assets | $99 | $45 | $50 | $87 |
| Total Curr. Assets | $1,838 | $1,585 | $1,510 | $1,588 |
| Property Plant & Equip (Net) | $538 | $546 | $523 | $524 |
| Goodwill | $596 | $597 | $597 | $597 |
| Intangibles | $588 | $650 | $689 | $732 |
| Long-Term Investments | $0 | $19 | $26 | $36 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $39 | $26 | $19 | $24 |
| Total NC Assets | $1,761 | $1,838 | $1,855 | $1,914 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,600 | $3,423 | $3,365 | $3,501 |
| Liabilities | – | – | – | – |
| Payables | $266 | $667 | $193 | $260 |
| Short-Term Debt | $21 | $335 | $338 | $340 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $574 | $105 | $546 | $530 |
| Total Curr. Liab. | $862 | $1,107 | $1,076 | $1,130 |
| LT Debt | $2,664 | $2,246 | $2,242 | $2,253 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $183 | $116 | $107 | $163 |
| Total NC Liab. | $2,848 | $2,362 | $2,349 | $2,416 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $112 | $114 | $104 | $107 |
| Total Liabilities | $3,710 | $3,470 | $3,425 | $3,546 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$570 | -$572 | -$595 | -$607 |
| AOCI | -$106 | -$97 | -$86 | -$66 |
| Other Equity | $563 | $555 | $546 | $560 |
| Total Equity | -$109 | -$113 | -$132 | -$109 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | $66 | $72 | $65 |
| Total Liab. & Tot. Equity | $3,600 | $3,423 | $3,365 | $3,501 |
| Net Debt | $2,484 | $2,501 | $2,520 | $2,483 |